医药-话题@MedSci

#医药#

1668篇内容 | 2736人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410064, encodeId=5ea11410064f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=第十一届中国（泰州）国际医药博览会开幕, objectType=article, longId=200940, objectId=cc6920094011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6920094011, replyNumber=0, likeNumber=63, createdTime=2020-09-21, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6920094011, moduleTitle=第十一届中国（泰州）国际医药博览会开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6920094011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410063, encodeId=180e1410063a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=最高法、医保局联手治理医药腐败，我们有何期待？, objectType=article, longId=200925, objectId=5ee2200925d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ee2200925d0, replyNumber=0, likeNumber=49, createdTime=2020-09-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ee2200925d0, moduleTitle=最高法、医保局联手治理医药腐败，我们有何期待？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ee2200925d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410062, encodeId=ba70141006271, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=资本盛宴上交所港交所深交所齐聚第五届中国医药创新与投资大会，共话医药产业创新发展新篇章, objectType=article, longId=200899, objectId=232220089974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=232220089974, replyNumber=0, likeNumber=71, createdTime=2020-09-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=232220089974, moduleTitle=资本盛宴上交所港交所深交所齐聚第五届中国医药创新与投资大会，共话医药产业创新发展新篇章, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=232220089974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410061, encodeId=f4271410061dc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=行业瞩目亮点纷呈丨第五届中国医药创新与投资大会精彩抢先看, objectType=article, longId=200898, objectId=e444200898da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e444200898da, replyNumber=0, likeNumber=48, createdTime=2020-09-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e444200898da, moduleTitle=行业瞩目亮点纷呈丨第五届中国医药创新与投资大会精彩抢先看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e444200898da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410060, encodeId=88441410060f2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=3款复方制剂通过一致性评价，来自华东医药、福元医药…, objectType=article, longId=200843, objectId=006420084354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=006420084354, replyNumber=0, likeNumber=60, createdTime=2020-09-19, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=006420084354, moduleTitle=3款复方制剂通过一致性评价，来自华东医药、福元医药…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=006420084354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410059, encodeId=53261410059bc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国家医保局：各地年底前建立医药价格和招采信用评价制度, objectType=article, longId=200772, objectId=4574200e72f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4574200e72f2, replyNumber=0, likeNumber=87, createdTime=2020-09-18, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4574200e72f2, moduleTitle=国家医保局：各地年底前建立医药价格和招采信用评价制度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4574200e72f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410058, encodeId=6921141005827, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, objectType=article, longId=200515, objectId=12af200515fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12af200515fe, replyNumber=0, likeNumber=0, createdTime=2020-09-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12af200515fe, moduleTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12af200515fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410057, encodeId=0394141005e44, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=复星医药产业拟超7.42亿元受让重庆药友约10.04%股权, objectType=article, longId=200500, objectId=43d320050002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d320050002, replyNumber=0, likeNumber=60, createdTime=2020-09-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d320050002, moduleTitle=复星医药产业拟超7.42亿元受让重庆药友约10.04%股权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43d320050002)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410056, encodeId=8d771410056ea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=万春医药First In Class新药普那布林获FDA突破性疗法认定, objectType=article, longId=200493, objectId=0b50200493e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b50200493e8, replyNumber=0, likeNumber=74, createdTime=2020-09-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b50200493e8, moduleTitle=万春医药First In Class新药普那布林获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b50200493e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410055, encodeId=a54d1410055a8, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=先通医药完成C轮融资，用于放射药项目临床前开发及临床研究, objectType=article, longId=200451, objectId=79ed20045153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79ed20045153, replyNumber=0, likeNumber=73, createdTime=2020-09-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79ed20045153, moduleTitle=先通医药完成C轮融资，用于放射药项目临床前开发及临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79ed20045153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410054, encodeId=782e14100542d, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, objectType=article, longId=200423, objectId=5feb2004238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5feb2004238f, replyNumber=0, likeNumber=60, createdTime=2020-09-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5feb2004238f, moduleTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5feb2004238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410053, encodeId=de0d141005399, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=“小而美”全球临床研究CRO普米尔医药步入中国市场，提供一站式药械临床服务, objectType=article, longId=200317, objectId=e1e520031e01, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1e520031e01, replyNumber=0, likeNumber=64, createdTime=2020-09-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1e520031e01, moduleTitle=“小而美”全球临床研究CRO普米尔医药步入中国市场，提供一站式药械临床服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1e520031e01)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410052, encodeId=8145141005269, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体, objectType=article, longId=199842, objectId=c7e719984239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e719984239, replyNumber=0, likeNumber=0, createdTime=2020-08-24, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e719984239, moduleTitle=和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e719984239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410051, encodeId=20ca14100512e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=北京健康大会：钟南山张伯礼等院士专家共议中医药防治新冠助力全球健康, objectType=article, longId=199803, objectId=47bb199803eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47bb199803eb, replyNumber=0, likeNumber=60, createdTime=2020-08-23, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47bb199803eb, moduleTitle=北京健康大会：钟南山张伯礼等院士专家共议中医药防治新冠助力全球健康, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47bb199803eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410050, encodeId=dec6141005080, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=千年古刹设国医堂为大众提供中医药特色服务, objectType=article, longId=199044, objectId=3bf019904480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf019904480, replyNumber=0, likeNumber=29, createdTime=2020-08-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf019904480, moduleTitle=千年古刹设国医堂为大众提供中医药特色服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bf019904480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410049, encodeId=a3a81410049f4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=【年度重磅】第37届全国医药工业信息年会详细议程揭晓！, objectType=article, longId=198975, objectId=8fed1989e528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fed1989e528, replyNumber=0, likeNumber=50, createdTime=2020-08-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fed1989e528, moduleTitle=【年度重磅】第37届全国医药工业信息年会详细议程揭晓！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fed1989e528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410048, encodeId=fd2e1410048c3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=速看！2020年度国家科学技术奖医药领域初评名单新鲜出炉！, objectType=article, longId=198715, objectId=179b198e15c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=179b198e15c5, replyNumber=0, likeNumber=16, createdTime=2020-08-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=179b198e15c5, moduleTitle=速看！2020年度国家科学技术奖医药领域初评名单新鲜出炉！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=179b198e15c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410047, encodeId=e054141004e0a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2019年度中国医药工业百强榜单发布，恒瑞再居化药企业之首, objectType=article, longId=197938, objectId=c73219e938f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c73219e938f5, replyNumber=0, likeNumber=74, createdTime=2020-07-24, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c73219e938f5, moduleTitle=2019年度中国医药工业百强榜单发布，恒瑞再居化药企业之首, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c73219e938f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410046, encodeId=293014100462e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=复星医药引进的新冠mRNA疫苗获批临床了, objectType=article, longId=197807, objectId=4ad419e80746, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ad419e80746, replyNumber=0, likeNumber=70, createdTime=2020-07-22, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ad419e80746, moduleTitle=复星医药引进的新冠mRNA疫苗获批临床了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ad419e80746)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410045, encodeId=608014100458d, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=广西提升中医药壮瑶医药服务能力加快建设基层中医馆, objectType=article, longId=197690, objectId=78fc19e690d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78fc19e690d4, replyNumber=0, likeNumber=61, createdTime=2020-07-19, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78fc19e690d4, moduleTitle=广西提升中医药壮瑶医药服务能力加快建设基层中医馆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78fc19e690d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

第十一届中国（泰州）国际医药博览会开幕

2020-09-21

cathymary (审核中...)

前往app查看评论内容

#医药#

最高法、医保局联手治理医药腐败，我们有何期待？

2020-09-20

cathymary (审核中...)

前往app查看评论内容

#医药#

资本盛宴上交所港交所深交所齐聚第五届中国医药创新与投资大会，共话医药产业创新发展新篇章

2020-09-20

cathymary (审核中...)

前往app查看评论内容

#医药#

行业瞩目亮点纷呈丨第五届中国医药创新与投资大会精彩抢先看

2020-09-20

cathymary (审核中...)

前往app查看评论内容

#医药#

3款复方制剂通过一致性评价，来自华东医药、福元医药…

2020-09-19

cathymary (审核中...)

前往app查看评论内容

#医药#

国家医保局：各地年底前建立医药价格和招采信用评价制度

2020-09-18

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发

2020-09-12

cathymary (审核中...)

前往app查看评论内容

#医药#

复星医药产业拟超7.42亿元受让重庆药友约10.04%股权

2020-09-11

cathymary (审核中...)

前往app查看评论内容

#医药#

万春医药First In Class新药普那布林获FDA突破性疗法认定

2020-09-11

cathymary (审核中...)

前往app查看评论内容

#医药#

先通医药完成C轮融资，用于放射药项目临床前开发及临床研究

2020-09-10

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病

2020-09-09

cathymary (审核中...)

前往app查看评论内容

#医药#

“小而美”全球临床研究CRO普米尔医药步入中国市场，提供一站式药械临床服务

2020-09-07

cathymary (审核中...)

前往app查看评论内容

#医药#

和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体

2020-08-24

cathymary (审核中...)

前往app查看评论内容

#医药#

北京健康大会：钟南山张伯礼等院士专家共议中医药防治新冠助力全球健康

2020-08-23

cathymary (审核中...)

前往app查看评论内容

#医药#

千年古刹设国医堂为大众提供中医药特色服务

2020-08-11

cathymary (审核中...)

前往app查看评论内容

#医药#

【年度重磅】第37届全国医药工业信息年会详细议程揭晓！

2020-08-09

cathymary (审核中...)

前往app查看评论内容

#医药#

速看！2020年度国家科学技术奖医药领域初评名单新鲜出炉！

2020-08-06

cathymary (审核中...)

前往app查看评论内容

#医药#

2019年度中国医药工业百强榜单发布，恒瑞再居化药企业之首

2020-07-24

cathymary (审核中...)

前往app查看评论内容

#医药#

复星医药引进的新冠mRNA疫苗获批临床了

2020-07-22

cathymary (审核中...)

前往app查看评论内容

#医药#

广西提升中医药壮瑶医药服务能力加快建设基层中医馆

2020-07-19

科室
- - 订阅+
  - 更多科室
工具
服务